ArrayRx highlights cost-saving achievements for Oregon Prescription Drug Program

During a recent meeting of the Oregon House Committee on Behavioral Health and Health Care, significant discussions centered around the Oregon Prescription Drug Program (OPDP) and its innovative approach to managing pharmacy benefits. The program, which serves over 300,000 residents in Oregon, has made notable strides in reducing costs and improving transparency in prescription drug pricing.

One of the key highlights was the introduction of ArrayRx, a unique pharmacy benefit manager (PBM) that operates without traditional spread pricing and ensures that rebates are passed directly to participating programs. This model is designed to enhance flexibility and accountability, allowing for tailored solutions that meet the diverse needs of various health plans. The committee emphasized that ArrayRx is overseen by a team of experts with extensive experience in both public and private pharmacy sectors, further ensuring that the program remains aligned with the best interests of its users.

The financial impact of OPDP was also a focal point, with reports indicating that the program saved its members nearly $6 million between 2022 and 2024 by avoiding spread pricing. Additionally, across all states served by the program, a total of $35 million was saved through similar measures, demonstrating the effectiveness of this approach in managing drug costs.

The meeting underscored the importance of collaboration between state agencies, with the Oregon Department of Justice and the Washington Attorney General's office involved in reviewing contracts to maintain compliance and protect consumer interests. This level of oversight is reportedly unmatched by other PBMs in the country.

As the committee continues to explore ways to enhance health care access and affordability, the developments surrounding OPDP and ArrayRx signal a proactive approach to addressing the rising costs of prescription medications, ultimately benefiting Oregonians and improving health outcomes across the state.